Cargando…

Translational Control of COVID-19 and Its Therapeutic Implication

The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the causative agent of COVID-19, which has broken out worldwide for more than two years. However, due to limited treatment, new cases of infection are still rising. Therefore, there is an urgent need to understand the basic molecula...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Dejiu, Zhu, Lei, Wang, Yin, Li, Peifeng, Gao, Yanyan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9002053/
https://www.ncbi.nlm.nih.gov/pubmed/35422818
http://dx.doi.org/10.3389/fimmu.2022.857490
_version_ 1784685810847580160
author Zhang, Dejiu
Zhu, Lei
Wang, Yin
Li, Peifeng
Gao, Yanyan
author_facet Zhang, Dejiu
Zhu, Lei
Wang, Yin
Li, Peifeng
Gao, Yanyan
author_sort Zhang, Dejiu
collection PubMed
description The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the causative agent of COVID-19, which has broken out worldwide for more than two years. However, due to limited treatment, new cases of infection are still rising. Therefore, there is an urgent need to understand the basic molecular biology of SARS-CoV-2 to control this virus. SARS-CoV-2 replication and spread depend on the recruitment of host ribosomes to translate viral messenger RNA (mRNA). To ensure the translation of their own mRNAs, the SARS-CoV-2 has developed multiple strategies to globally inhibit the translation of host mRNAs and block the cellular innate immune response. This review provides a comprehensive picture of recent advancements in our understanding of the molecular basis and complexity of SARS-CoV-2 protein translation. Specifically, we summarize how this viral infection inhibits host mRNA translation to better utilize translation elements for translation of its own mRNA. Finally, we discuss the potential of translational components as targets for therapeutic interventions.
format Online
Article
Text
id pubmed-9002053
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-90020532022-04-13 Translational Control of COVID-19 and Its Therapeutic Implication Zhang, Dejiu Zhu, Lei Wang, Yin Li, Peifeng Gao, Yanyan Front Immunol Immunology The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the causative agent of COVID-19, which has broken out worldwide for more than two years. However, due to limited treatment, new cases of infection are still rising. Therefore, there is an urgent need to understand the basic molecular biology of SARS-CoV-2 to control this virus. SARS-CoV-2 replication and spread depend on the recruitment of host ribosomes to translate viral messenger RNA (mRNA). To ensure the translation of their own mRNAs, the SARS-CoV-2 has developed multiple strategies to globally inhibit the translation of host mRNAs and block the cellular innate immune response. This review provides a comprehensive picture of recent advancements in our understanding of the molecular basis and complexity of SARS-CoV-2 protein translation. Specifically, we summarize how this viral infection inhibits host mRNA translation to better utilize translation elements for translation of its own mRNA. Finally, we discuss the potential of translational components as targets for therapeutic interventions. Frontiers Media S.A. 2022-03-29 /pmc/articles/PMC9002053/ /pubmed/35422818 http://dx.doi.org/10.3389/fimmu.2022.857490 Text en Copyright © 2022 Zhang, Zhu, Wang, Li and Gao https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Immunology
Zhang, Dejiu
Zhu, Lei
Wang, Yin
Li, Peifeng
Gao, Yanyan
Translational Control of COVID-19 and Its Therapeutic Implication
title Translational Control of COVID-19 and Its Therapeutic Implication
title_full Translational Control of COVID-19 and Its Therapeutic Implication
title_fullStr Translational Control of COVID-19 and Its Therapeutic Implication
title_full_unstemmed Translational Control of COVID-19 and Its Therapeutic Implication
title_short Translational Control of COVID-19 and Its Therapeutic Implication
title_sort translational control of covid-19 and its therapeutic implication
topic Immunology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9002053/
https://www.ncbi.nlm.nih.gov/pubmed/35422818
http://dx.doi.org/10.3389/fimmu.2022.857490
work_keys_str_mv AT zhangdejiu translationalcontrolofcovid19anditstherapeuticimplication
AT zhulei translationalcontrolofcovid19anditstherapeuticimplication
AT wangyin translationalcontrolofcovid19anditstherapeuticimplication
AT lipeifeng translationalcontrolofcovid19anditstherapeuticimplication
AT gaoyanyan translationalcontrolofcovid19anditstherapeuticimplication